BD
SummitYüz yüze
BioPharma Deals BD&L Summit 2026
Ev sahibi BioPharma Deals
- 24 – 25 November 2026
Takvime ekle
kongre.net'e hoş geldiniz - Science Congress Center Munich, Munich, Germany
- Tıp ve Sağlık Bilimleri, İşletme, Ekonomi ve Hukuk
Orada olacağınızı başkalarına bildirin. Bu işlem sizi etkinliğe kaydetmez.
kongre.net'e hoş geldiniz
kongre.net'e hoş geldiniz
Temel bilgiler
BioPharma Deals BD&L Summit 2026, BioPharma Deals tarafından 24 – 25 Kasım 2026 tarihlerinde Science Congress Center Munich, Munich, Almanya konumunda düzenlenen bir zirve etkinliğidir.
- Tarihler:
- 24 – 25 Kasım 2026
- Biçim:
- Yüz yüze
- Mekân:
- Science Congress Center Munich, Munich, Almanya
- Konular:
- Medical & Health Sciences, Business, Economics & Law
- Organizatör:
- BioPharma Deals
- Resmi web sitesi:
- biopharmadeals.com
The BioPharma Deals Conference unites global biopharma executives, investors, and dealmakers to explore licensing opportunities, strategic partnerships, co-development, M&A, and commercial collaborations.
Konferans teması
Europe's Premier Life Sciences Dealmaking Summit
Hedefler
To discover transformative opportunities, strategic partnerships, and high value deals, accelerating innovation and business growth in life sciences.
Kimler katılmalı
Senior-level BD&L leaders from pharma, biotech & life sciences, including Chief BD Officers, biotech CEOs, life sciences investors, licensing directors, M&A leaders, and legal/IP advisors.
Programdan öne çıkanlar
Programın tamamını görSpeakers
Konuşmacıları gör- Dimitri F. Dimitriou - Managing Director, DyoDelta Biosciences Ltd.
- Caroline Robic - R&D Due Diligence Director, Servier
- Dr. Ralf Angermund - Director Search & Evaluation Germany, External Scientific Innovation, Johnson & Johnson Innovative Medicine
- Benjamin August - Senior Director, Search & Evaluation - Research & Technologies, Daiichi Sankyo
- Berthold Hinzen, Ph. D. - Corporate & Business Development, Global Head of Due Diligence, Novartis
- Akiko Tanabe - Scouting & Transaction Lead, Business Development, Astellas Pharma Europe
- Dr. Vinay Pawar - Scientific Director (Data and AI), R&D External Innovation, Novo Nordisk
- Isabelle Scarabin - Director, Business Licensing Officer & Alliance Manager, Bayer
- Monika Baudler-Klein - Executive Director, Alliance & Assetmanagement, Pharma Partnering, Roche
- Ricardo Gaminha Pacheco, MD MBA MPH - Longevity Biotechnology Strategic Partnering, BD&L Senior Director, Insilico Medicine
- Christian Kuttruff - Director, Global Business Development & Licensing, Boehringer Ingelheim
- Martin Svorc - Director, Neurology & Immunology, Business Development & AI Strategy and Enablement Lead, Merck
Organizatör ve iletişim
Ev sahibi kuruluş
BioPharma Dealsİletişim
- E-posta:
- [email protected]
Reklam
İlgili etkinlikler
- Beyond basics: Endoscopic stone treatment programme step 2 (ESTs2) 2026Hamburg, Almanya10–11 Nov 2026
- The Liver Meeting 2026Denver, Amerika Birleşik Devletleri5–9 Nov 2026
- 57th RANZCO Annual Scientific CongressAuckland, Yeni Zelanda6–9 Nov 2026
- 3rd Asia Conference on Environmental Economics and PolicyTokyo, Japonya6–9 Nov 2026
- 3rd Stem Cell - Niche Interactions in the Gastrointestinal Tract ConferencePlaya del Carmen, Meksika7–10 Nov 2026
- ISPOR Europe 2026Vienna, Avusturya8–11 Nov 2026